These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29297515)

  • 1. Erratum: Field JJ, Majerus E, Gordeuk VR, et al. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.
    Blood Adv; 2017 Oct; 1(23):2058. PubMed ID: 29297515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.
    Field JJ; Majerus E; Gordeuk VR; Gowhari M; Hoppe C; Heeney MM; Achebe M; George A; Chu H; Sheehan B; Puligandla M; Neuberg D; Lin G; Linden J; Nathan DG
    Blood Adv; 2017 Sep; 1(20):1645-1649. PubMed ID: 29296811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Reina-Castillón J, Pujol R, López-Sánchez M, et al. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.
    Blood Adv; 2017 Aug; 1(18):1368. PubMed ID: 29297518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation.
    Blood Adv; 2017 Dec; 1(26):2535. PubMed ID: 29297517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy.
    Blood Adv; 2018 Jan; 2(1):75. PubMed ID: 29345695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL.
    Blood Adv; 2017 Aug; 1(19):1537. PubMed ID: 29297516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
    Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to: Tranexamic acid use in a patient with sickle cell disease undergoing posterior scoliosis correction surgery: safely mitigating bleeding and vaso-occlusive crises.
    Newall M; Hamdan TA; Ajayi B; Weil S; Bishop T; Lui DF
    J Surg Case Rep; 2021 May; 2021(5):rjab229. PubMed ID: 34040756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presentation and management of the acute abdomen in the patient with sickle-cell anemia.
    Baumgartner F; Klein S
    Am Surg; 1989 Nov; 55(11):660-4. PubMed ID: 2817619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ET-1 and ecNOS gene polymorphisms andsusceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia.
    Chaar V; Tarer V; Etienne-Julan M; Diara JP; Elion J; Romana M
    Haematologica; 2006 Sep; 91(9):1277-8. PubMed ID: 16956834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology and treatment of sickle-cell disease].
    van Beers EJ; Peters M; Biemond BJ
    Ned Tijdschr Geneeskd; 2005 May; 149(21):1144-9. PubMed ID: 15940917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual causes of abdominal pain: sickle cell anemia.
    Ahmed S; Shahid RK; Russo LA
    Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):297-310. PubMed ID: 15833695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M; Tobin JR; Billett C; Casella JF; Dover G
    Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.